Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

David Berman, M.D., Ph.D., assistant professor of pathology, oncology and urology at Johns Hopkins, discusses the different ways he and his lab are looking at how prostate cancer develops.

David Berman, M.D., Ph.D., assistant professor of pathology, oncology and urology at Johns Hopkins, discusses the different ways he and his lab are looking at how prostate cancer develops.

listen   Listen to podcast now

Program Notes:

David Berman, M.D., Ph.D.

0:21   It's a different way of looking at how cancer develops
1:28   Each of these cells uses different components
2:35   Genes being assigned different functional characteristics
3:32   We can find all the genes in the pathway
4:40   Now we can use a reproducible system
5:44   Is nestin a good target for therapy?
6:39   Understanding the lineage of a cancer cell important
7:30   More of a therapeutic target than a way to predict
8:54   Shift means more aggressive tumor type?
10:01 End

 

Additional Johns Hopkins Podcasts

 

Sign Up for e-News

Subscribe to the JHM Update for the latest news from Johns Hopkins Medicine.

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5464
U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer